ArticleThe Journal of clinical investigation2008

Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.

Cedric Ghevaert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.